Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arabin Pessary and Progesterone for Preterm Birth Prevention
NCT03052270Phase 3Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in preterm birth (2 arms), sponsored by University of Illinois Chicago. Primary endpoint: Preterm delivery prior to 37 weeks. Started Jan 2017; status: terminated.
02
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03052270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052270.